Menu
← Oncology Approval Tracker
FDA DECISION ·
Romidepsin injection
romidepsin · Teva Pharmaceuticals USA
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with cutaneous T-cell lymphoma who had received at least one systemic therapy.
LAMPGEN ANALYSIS
Why it matters
Added a liquid injectable formulation of an established histone deacetylase inhibitor for previously treated cutaneous disease.
What research teams should watch
Use solution-specific dilution instructions and confirm the qualifying prior systemic regimen.
PRIMARY RECORDS